Skip to content
MedsAcross

Brand family

Quviviq

Daridorexant · Idorsia Pharmaceuticals
United States
Presentations
2
Markets
1

Quviviq is a brand of Daridorexant marketed by Idorsia Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Daridorexant
Brand owner
Idorsia Pharmaceuticals
Registered in
United States
Strengths and forms
25 mg tablet, 50 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Quviviq 25 mg tabletOralIdorsia PharmaceuticalsUS FDAAvailable on request
Quviviq 50 mg tabletOralIdorsia PharmaceuticalsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Quviviq

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.